This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Napoleon Ferrara: Innovator in Angiogenesis Inhibition
Introduction
Napoleon Ferrara is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of medical research, particularly in the area of angiogenesis inhibition. His work focuses on the prevention and treatment of tumor angiogenesis, which is crucial for cancer therapy.
Latest Patents
Ferrara holds a patent related to the inhibition of inflammatory cell-mediated angiogenesis. This invention specifically addresses the prevention or treatment of tumor angiogenesis using Bv8 antagonists, such as anti-Bv8 antibodies. He has 1 patent to his name, showcasing his innovative approach to tackling cancer development.
Career Highlights
Napoleon Ferrara is associated with Genentech, Inc., a leading biotechnology company known for its groundbreaking work in pharmaceuticals. His role at Genentech has allowed him to contribute to significant advancements in cancer treatment and research.
Collaborations
Ferrara has collaborated with notable colleagues, including Farbod Shojaei and Xiumin Wu. These partnerships have further enhanced his research and development efforts in the field of angiogenesis.
Conclusion
Napoleon Ferrara's work in the inhibition of angiogenesis represents a vital advancement in cancer treatment. His innovative patent and collaboration with esteemed colleagues highlight his commitment to improving medical outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile